Celiac Disease Research and Management / Obesity, Physical Activity, Diet / Gastrointestinal Motility and Disorders · Journal article
Journal of Eating Disorders · July 7, 2026
Encouraging direction, but not yet definitive.
This cross-sectional study found ARFID present in 42.6% of children and adolescents with biopsy-confirmed celiac disease at a tertiary-care centre. Children with ARFID showed significantly worse anthropometric measures, higher rates of bone and micronutrient problems, and greater anxiety, depression, and reduced quality of life compared to those without ARFID; gastrointestinal symptoms and anxiety scores were independently associated with ARFID presence.
Single-centre cross-sectional study. Children and adolescents aged 8–17 years with biopsy-confirmed celiac disease attending a tertiary-care centre; n=101 analysed.. Intervention: ARFID assessment and multidisciplinary clinical evaluation. n = 101. Single tertiary-care centre (location not specified in text).
ARFID prevalence 42.6% in children and adolescents with celiac disease (n=101) Children with ARFID had significantly lower weight z-scores (p < 0.001) and BMI z-scores (p = 0.002) Higher prevalence of osteopenia/osteoporosis in ARFID group (p = 0.005)
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians managing pediatric celiac disease should recognize that food restriction often extends beyond medically necessary gluten avoidance and may represent clinically significant ARFID with substantial physical and psychosocial burden. Presence of gastrointestinal symptoms and anxiety symptoms should prompt screening and multidisciplinary assessment including psychiatry and psychology.
Single-centre cross-sectional study identifying a high prevalence of ARFID in pediatric celiac disease with plausible clinical correlates, but lacks a control group and relies on observational design to establish associations rather than causation.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians managing pediatric celiac disease should recognize that food restriction often extends beyond medically necessary gluten avoidance and may represent clinically significant ARFID with substantial physical and psychosocial burden. Presence of gastrointestinal symptoms and anxiety symptoms should prompt screening and multidisciplinary assessment including psychiatry and psychology.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Avoidant/Restrictive Food Intake Disorder (ARFID) may represent a clinically important problem in celiac disease (CD), where lifelong dietary restriction, ongoing gastrointestinal symptoms, and food-related anxiety may promote food avoidance beyond gluten-containing foods and contribute to maladaptive eating patterns. Although adult studies have reported high rates of ARFID symptoms in CD, pediatric data are limited. This study aimed to evaluate the prevalence and clinical correlates of ARFID in children and adolescents with CD using a multidisciplinary assessment approach involving pediatric gastroenterology and child and adolescent psychiatry specialists, including anthropometric, nutritional, bone health, psychological, and health-related quality-of-life (QoL) correlates. A cross-sectional study was conducted at a tertiary-care center involving children and adolescents aged 8–17 years with biopsy-confirmed CD (n = 101). Participants were assessed using a combination of clinical interviews and psychometric scales, including the Nine Item ARFID Screen (NIAS), the Revised Child Anxiety and Depression Scale (RCADS), and the Pediatric QoL Inventory (PedsQL). ARFID diagnosis was established through a DSM-5-guided clinical evaluation by two child and adolescent psychiatrists, and clinical and anthropometric data were collected alongside laboratory results. Multivariable regression models were used to identify factors independently associated with ARFID and clinical outcomes. The prevalence of ARFID in the cohort was 42.6%. Children with ARFID exhibited significantly lower weight and BMI z-scores (p < 0.001 and p = 0.002, respectively), a higher prevalence of osteopenia/osteoporosis (p = 0.005) and micronutrient deficiencies (p < 0.001), poorer QoL (p < 0.001), and higher anxiety and depressive symptom scores (p < 0.001 and p = 0.003, respectively). Presence of gastrointestinal symptoms and higher anxiety score were independently associated with ARFID in children and adolescents with CD. In this cohort, ARFID appeared to be a clinically relevant comorbidity in pediatric CD, with adverse physical and psychosocial correlates. Restrictive eating extending beyond gluten avoidance should be recognized during clinical assessment, particularly in children with gastrointestinal symptoms, prominent anxiety symptoms, poor weight gain, or persistent micronutrient deficiencies. Longitudinal studies are needed to clarify the clinical course of ARFID symptoms and to inform targeted multidisciplinary care in this population. Celiac disease requires lifelong treatment with a strict gluten-free diet. In some children and adolescents, eating difficulties may extend beyond avoiding gluten and develop into avoidant/restrictive food intake disorder (ARFID), an eating disorder marked by very limited eating that is not driven by body image concerns. In celiac disease, ongoing digestive symptoms, fear of symptoms after gluten exposure, and the burden of following a strict diet may increase vulnerability to this problem. This study examined how common ARFID was in young people with celiac disease and explored its clinical features. ARFID was identified in 42.6% of the study group. Children and adolescents with ARFID had lower weight, more nutritional problems, weaker bone health, more anxiety and depression symptoms, and lower quality of life than those without ARFID. Ongoing gastrointestinal symptoms and higher anxiety symptoms were the factors most strongly linked with ARFID. These findings suggest that when food restriction extends beyond medically necessary dietary rules, it may indicate a more serious eating problem with both physical and emotional effects. Care for young people with celiac disease may benefit from a multidisciplinary approach that includes pediatric gastroenterology, child and adolescent psychiatry, dietetics, and psychological support.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.